Understanding early skull suture fusion in babies (craniosynostosis)
Molecular and Cellular Basis of Craniosynostosis
This project aims to find how and why skull sutures fuse too early in babies with craniosynostosis so researchers can develop less invasive ways to prevent repeated surgeries.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11136362 on NIH RePORTER |
What this research studies
Researchers are using a zebrafish model of Saethre-Chotzen syndrome to trace where the stem cells that keep skull sutures open come from and how early bone growth leads to fusions. They use genetic tools such as CRISPR to change specific genes and watch the effects on embryonic skull growth and suture formation. The team will map the cellular origins of suture stem cells and pinpoint molecular events that trigger fusing. The long-term goal is to turn those findings into treatments that lower the need for risky repeat surgeries in infants.
Who could benefit from this research
Good fit: Infants and children diagnosed with craniosynostosis, including genetic forms like Saethre-Chotzen syndrome, are the patients most likely to benefit from therapies that come from this research.
Not a fit: People without craniosynostosis or adults whose skull sutures are already fused and stable are unlikely to receive direct benefit from this project.
Why it matters
Potential benefit: If successful, this work could point to therapies that stop sutures from re-fusing and reduce or eliminate the need for repeated skull surgeries in affected children.
How similar studies have performed: Previous lab and animal studies have identified genes linked to craniosynostosis and this group developed the first zebrafish model for Saethre-Chotzen, but translating such findings into human treatments is still largely unproven.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Crump, Gage D — University of Southern California
- Study coordinator: Crump, Gage D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.